GlassScriptPhysician profile
Laura D Lebel
NPI 1972694016
$10,154.72
in general payments reported to CMS, 2019-2025
49 companies · $1,189 in 2025
The $1,189 reported for 2025 was more than what 92% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,275 · 2020: $816 · 2021: $1,819 · 2022: $1,225 · 2023: $1,383 · 2024: $1,448 · 2025: $1,189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,820 · Education: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,819.57 |
| Education | $199.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,248.13 | 2019-2025 | |
| Coloplast Corp | $1,309.23 | 2019-2025 | Altis |
| Astellas Pharma US INC | $601.01 | 2019-2025 | Veozah, Myrbetriq |
| Currax Pharmaceuticals LLC | $547.75 | 2020-2025 | Contrave |
| Sumitomo Pharma America, INC. | $459.12 | 2023-2025 | Myfembree |
| Minerva Surgical, INC | $422.81 | 2019-2021 | |
| Pfizer INC. | $418.01 | 2019-2025 | |
| Mayne Pharma Commercial LLC | $413.72 | 2022-2025 | |
| Daiichi Sankyo INC. | $358.13 | 2019-2024 | Injectafer |
| Therapeuticsmd, INC. | $317.06 | 2019-2022 | |
| Gynesonics, INC. | $248.44 | 2022-2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Sage Therapeutics, LLC | $221.68 | 2024-2025 | Zurzuvae |
| Coopersurgical, INC. | $215.85 | 2019-2025 | Summit Doppler, Endosee |
| Allergan, INC. | $205.34 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $192.58 | 2019-2021 |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Lebel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.